Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.51 $0 (0%) RKDA stock closing price Jul 21, 2017 (Closing)

The Arcadia Biosciences cash flow statement is one of the three reports that the company generates every quarter. The profit-loss statement shows Arcadia Biosciences profits, the balance sheet shows Arcadia Biosciences debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Arcadia Biosciences cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents.  Arcadia Biosciences had cash and cash equivalents of $23.97M at the beginning of the year and $2.01M at year end for 2016.   Arcadia Biosciences saw a inflow of $41.06M from investing activities for 2016. View details of Arcadia Biosciences cash flows for latest & last ten financial years.

show more
Fiscal year is Jan - Dec. 2016 2015 2014 2013
Arcadia Biosciences Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow0.44M0.37M0.35M0.39M
Net Increase (Decrease) in Assets Liabilities0.86M-0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations----
Other Adjustments Net1.26M2.52M4.53M3.2M
Arcadia Biosciences Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.23M-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires---1.45M-0.5M
Increase (Decrease) in Investments-5.07M-46.21M--
Other Cash Inflow (Outflow) from Investment Activities----
Arcadia Biosciences Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares0.44M68.58M32.86M0.01M
Issuance (Repayment) of Debt Securities-10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities
Arcadia Biosciences Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Arcadia Biosciences Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year23.97M16.57M2.83M5.35M
Cash & Equivalents at Year End2.01M23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Cash flow for another ticker

Arcadia Biosciences stock comparison chart provides an easy way to compare the stock price with peers along with details of Arcadia Biosciences stock price history.
The statement of cash flows can be categorized into three main sections:
  • Arcadia Biosciences had a Net Change in Cash and Cash Equivalents of $-21.96M for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Arcadia Biosciences stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Arcadia Biosciences decreased its cash from operating activities to $1.95M in 2016. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $-17.05M for RKDA in last year report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $0.39M for Arcadia Biosciences. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin